1. Favorable early vessel healing after everolimus-eluting stent implantation: 3-, 6-, and 12-month follow-up of optical coherence tomography
- Author
-
Tomofumi Takaya, Ryo Nishio, Toshiro Shinke, Tsuyoshi Osue, Hiromasa Otake, Hiroto Kinutani, Hachidai Takahashi, Akihide Konishi, Junya Shite, Daisuke Terashita, Masaru Kuroda, Masamichi Iwasaki, and Ken-ichi Hirata
- Subjects
Male ,Neointima ,medicine.medical_specialty ,Everolimus eluting stent ,medicine.medical_treatment ,Lumen (anatomy) ,030204 cardiovascular system & hematology ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Optical coherence tomography ,Internal medicine ,medicine ,Humans ,Everolimus ,Postoperative Period ,Prospective Studies ,030212 general & internal medicine ,Aged ,Randomized Controlled Trials as Topic ,Heart Valve Prosthesis Implantation ,Neointimal hyperplasia ,Wound Healing ,Hyperplasia ,medicine.diagnostic_test ,business.industry ,Stent ,Drug-Eluting Stents ,Middle Aged ,medicine.disease ,Coronary Vessels ,Treatment Outcome ,Cardiology ,Female ,Cardiology and Cardiovascular Medicine ,business ,Nuclear medicine ,Early phase ,Tomography, Optical Coherence ,Follow-Up Studies ,Month follow up - Abstract
Background Although a prospective randomized control study revealed that 3-month dual anti-platelet therapy (DAPT) is safe and does not compromise the efficacy of everolimus-eluting stent (EES) in selected patients, detailed vessel healing at early phase after EES implantation has yet to be investigated in Japanese patients. Methods and results A total of 27 lesions in 19 patients treated with EES were serially evaluated by using optical coherence tomography (OCT) at 3, 6, and 12 months after stent implantation. In addition to standard quantitative OCT parameters, the percentage of stents with peri-strut low-intensity area (PLIA, a region around stent struts homogenously showing lesser intensity than the surrounding tissue, suggesting fibrin deposition or impaired neointima maturation) and that with in-stent thrombi were evaluated. There was a significant, but small increase in neointimal thickness (63 ± 17 μm; 83 ± 30 μm; and 111 ± 44 μm, respectively; p = 0.006) and small decrease in average lumen area (6.80 ± 2.57 mm2, 6.62 ± 2.58 mm2, 6.33 ± 2.58 mm2, p = 0.038) from the 3- to the 12-month follow-up. The incidences of uncovered and malapposed struts were low at 3 months and did not significantly change at 6 months and 12 months (3.01 ± 4.43; 2.45 ± 3.75; and 1.47 ± 3.16, p = 0.143, and 0.75 ± 0.65; 0.63 ± 0.73; and 0.58 ± 1.42, p = 0.162, respectively). Also, frequency of struts with PLIA was already low at three months and significantly decreased during the follow-up (6.4 ± 6.5; 4.6 ± 5.4; and 2.3 ± 3.3, respectively; p = 0.001). Conclusion Favorable vessel healing was achieved at 3 months after EES implantation without neointimal hyperplasia which was persistently suppressed up to 12 months.
- Published
- 2018